Show news: from last 30 days (default), 60 days, 90 days, last visit or all

Levomepromazine 25mg/mL injection shortage

17th April 2019

There is a shortage of levomepromazine 25mg/mL injection in the UK, with both the manufacturer (Sanofi) and the only other UK supplier (Wockhardt) out of stock. Further stock is not anticipated until the end of April 2019.

Click here to view

click here to view

CME T34 syringe pumps now require foam pads to be added to the battery compartment

3rd April 2019

All Caesarea Medical Electronics (CME) T34 Ambulatory syringe pumps now need a foam pad to be added to the battery compartment to ensure the battery rests securely against the contacts. Kits should be ordered from CME to do this.

This information is in the latest CME field safety notice (FSN2018-001_Updated) and follows the previous alerts in March and September 2018, highlighting the possible loss of function due to inadequate battery connection.

Click here to view

click here to view

Gabapentin and pregabalin are now controlled drugs

1st April 2019

Gabapentin and pregabalin were reclassified as Schedule 3 controlled drugs, on 1 April 2019, under the Misuse of Drugs Regulations 2001 (see our previous news item), with exemption from safe custody.

Full controlled drug prescription writing and requisition requirements for Schedule 3 controlled drugs are required for supply. However, gabapentin and pregabalin do not need to be stored in a separate locked controlled drug cabinet. Information and answers to frequently asked questions are available on the Royal Pharmaceutical Society support alert.

Click here to view

click here to view